Meridian Investment Counsel’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-10,000
| Closed | -$210K | – | 184 |
|
|
2020
Q2 | $210K | Hold |
10,000
| – | – | 0.11% | 159 |
|
|
2020
Q1 | $122K | Hold |
10,000
| – | – | 0.08% | 159 |
|
|
2019
Q4 | $147K | Hold |
10,000
| – | – | 0.07% | 179 |
|
|
2019
Q3 | $134K | Hold |
10,000
| – | – | 0.07% | 169 |
|
|
2019
Q2 | $164K | Hold |
10,000
| – | – | 0.09% | 169 |
|
|
2019
Q1 | $171K | Hold |
10,000
| – | – | 0.1% | 170 |
|
|
2018
Q4 | $136K | Hold |
10,000
| – | – | 0.09% | 157 |
|
|
2018
Q3 | $286K | Hold |
10,000
| – | – | 0.16% | 138 |
|
|
2018
Q2 | $274K | Hold |
10,000
| – | – | 0.15% | 141 |
|
|
2018
Q1 | $211K | Hold |
10,000
| – | – | 0.12% | 163 |
|
|
2017
Q4 | $192K | Hold |
10,000
| – | – | 0.1% | 175 |
|
|
2017
Q3 | $248K | Hold |
10,000
| – | – | 0.14% | 151 |
|
|
2017
Q2 | $160K | Hold |
10,000
| – | – | 0.1% | 167 |
|
|
2017
Q1 | $141K | Buy |
+10,000
| New | +$141K | 0.09% | 171 |
|